Ruchefsky Steven B

Director at Kite Pharma, Inc.

Sold, on record
$1.8M
Dollars the filings state
Form 4 sales
1
Latest Jun 14, 2017
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Kite Pharma, Inc.Plan not stated
    Jun 14 2017

    Sold 20,000 shares at $89.48 ($1.8M)

    Ruchefsky Steven B, Director

    Sold 8.9% of holdings ($20.2M position)205,426 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Ruchefsky Steven B
Source
Jun 14, 2017Kite Pharma, Inc.DirectorForm 4 sale20,000$1.8M8.9%Plan not statedSEC